Brief: Scope Fluidics Subsidiary Gets To "Proof-Of-Concept" Stage For Panel Detecting SARS-CoV-2
15/05/2020 08:24
May 15 (Reuters) - Scope Fluidics SA SCPP.WA :
* SAYS CURIOSITY DIAGNOSTICS GETS TO STAGE OF
"PROOF-OF-CONCEPT"
IN DEVELOPMENT OF PANEL ALLOWING TO CONDUCT TEST ON SARS-COV-2
PRESENCE WITH USAGE OF PCR|ONE SYSTEM
Source text for Eikon: ID:nEM74jMmMa
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics' EDOCERA Project Meets Second Goal Of Developing Prototype Of Device For Detecting Stroke Symptoms
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project